Treatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS)

NCT02071199 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Gingivitis

Interventions

DRUG: 1X ACCS (Amnion-derived Cellular Cytokine Solution)
DRUG: Normal saline
DRUG: 0.3X ACCS

Sponsor

Noveome Biotherapeutics, formerly Stemnion